Chief Business Development Officer

Dr Sonja Flott leads and manages the Olivia Newton-John Cancer Research Institute’s identification, development, and protection of intellectual property to facilitate innovation and commercialisation, which enables the institute’s mission to discover and develop breakthrough cancer therapies.

With a scientific background in cancer research and holding a PhD from the University of Dundee, she pursued postdoctoral research at the Gurdon Institute at the University of Cambridge, United Kingdom, specialising in genome stability maintenance, DNA repair and DNA damage response signalling.

Furthermore, she has experience in business development across both industry and academia, eight years of expertise in business development, portfolio management and product development at Abcam plc in Cambridge, and five years in commercialisation and business development at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, focusing on the advancement of immuno-oncology technologies.